skip to Main Content

Innovative 3C Patch® System for Wound Management

We have developed an automated process so that clinicians can offer autologous therapy using only a few minutes of clinician time.

Our proprietary automated system provides a robust blood derived patch prepared directly at the point of care.

Our solution is unique in its ability to provide an autologous product with the physical strength and integrity to be cut to shape if needed and placed directly on the wound site.

3CPatch_Helena_26-800-Reapplix

Our product the 3C Patch® System

Please visit our 3C Patch® website. Our technology is continuously supported with high standards of clinical evidence to demonstrate effectiveness in managing non-healing wounds.

Throughout our product website we aim to outline our evidence base and we are proud to share the results from the most recent multi-national, multi-center clinical trial on 269 patients with hard-to-heal diabetic foot ulcers using our technology.

350
MILLION CASES

WHO Global Report 2012

In 2012, the WHO Global Report1 on diabetes found diabetes has almost quadrupled since 1980 to 422 million adults. The report calls upon governments to ensure health systems are able to diagnose, treat and care for people with diabetes. Our intention, with our new product, is to help answer this call for support.

REFERENCES

1. WHO Report http://www.who.int/diabetes/en/

Back To Top
X